Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Indolent Non-hodgkin Lymphoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT00574730
What this trial is testing

CHOP/Rituximab Followed by Maintenance PEG Intron in Treatment of Indolent/Follicular Non-Hodgkin's Lymphoma

Who this might be right for
Non-Hodgkins Lymphoma
University of Nebraska 27
Testing effectiveness (Phase 2)Study completedNCT00868608
What this trial is testing

Study Evaluating Inotuzumab Ozogamicin (CMC-544) In Indolent Non-Hodgkins Lymphoma

Who this might be right for
Lymphoma
Pfizer 81
Large-scale testing (Phase 3)Ended earlyNCT01732926
What this trial is testing

Efficacy and Safety of Idelalisib (GS-1101) in Combination With Bendamustine and Rituximab for Previously Treated Indolent Non-Hodgkin Lymphomas

Who this might be right for
Indolent Non-Hodgkin's Lymphomas
Gilead Sciences 475
Testing effectiveness (Phase 2)Ended earlyNCT01799889
What this trial is testing

Study to Evaluate Efficacy, Safety, Tolerability, and Pharmacodynamics of Entospletinib in Adults With Relapsed or Refractory Hematologic Malignancies

Who this might be right for
Chronic Lymphocytic LeukemiaMantle Cell LymphomaDiffuse Large B-cell Lymphoma+2 more
Gilead Sciences 326
Testing effectiveness (Phase 2)Study completedNCT03583424
What this trial is testing

Venetoclax, Carmustine, Etoposide, Cytarabine, and Melphalan Before Stem Cell Transplant in Treating Participants With Relapsed or Refractory Non-Hodgkin Lymphoma

Who this might be right for
Hematopoietic Cell Transplantation RecipientRecurrent Diffuse Large B-Cell LymphomaRecurrent Grade 1 Follicular Lymphoma+9 more
Ohio State University Comprehensive Cancer Center 19
Testing effectiveness (Phase 2)Study completedNCT01108341
What this trial is testing

Study to Evaluate the Efficacy and Safety of Treatment With Bendamustine in Combination With Ofatumumab in Previously Untreated Patients With Indolent B-Cell Non-Hodgkin's Lymphoma (NHL)

Who this might be right for
Non-Hodgkin's Lymphoma (NHL)
Cephalon 50
Testing effectiveness (Phase 2)UnknownNCT00081783
What this trial is testing

Xcellerated T CellsTM for Non-Hodgkin's Lymphoma (NHL) Patients

Who this might be right for
Non-Hodgkin's Lymphoma
Xcyte Therapies 40
Testing effectiveness (Phase 2)UnknownNCT03261349
What this trial is testing

Antiviral Agent HARVONI® for the Treatment of HCV-associated Indolent B-Cell Lymphoma

Who this might be right for
Indolent Lymphoma
National Taiwan University Hospital 21
Large-scale testing (Phase 3)Study completedNCT01073163
What this trial is testing

Study to Assess the Effect of Treatment With Bendamustine in Combination With Rituximab on QT Interval in Patients With Advanced Indolent Non-Hodgkin's Lymphoma (NHL) or Mantle Cell Lymphoma (MCL)

Who this might be right for
Non-Hodgkin's LymphomaMantle Cell Lymphoma
Cephalon 54
Testing effectiveness (Phase 2)Study completedNCT00426855
What this trial is testing

Bendamustine and Bortezomib Combination Therapy in Indolent Non-Hodgkin's Lymphoma(NHL)

Who this might be right for
Lymphoma, Non-Hodgkin
Peter Moosmann 12
Large-scale testing (Phase 3)Study completedNCT02367040
What this trial is testing

Copanlisib and Rituximab in Relapsed Indolent B-cell Non-Hodgkin's Lymphoma (iNHL)

Who this might be right for
Lymphoma,Non-Hodgkin
Bayer 458
Testing effectiveness (Phase 2)Looking for participantsNCT06986174
What this trial is testing

Evaluate the Safety and Efficacy of Pacritinib in Relapsed or Refractory Waldenström Macroglobulinemia

Who this might be right for
Waldenström MacroglobulinemiaLymphoplasmacytic LymphomaB-Cell Lymphoproliferative Disorder+1 more
Shayna Sarosiek, MD 30
Testing effectiveness (Phase 2)Study completedNCT00004198
What this trial is testing

Vaccine Therapy Plus Sargramostim Following Chemotherapy in Treating Stage III or Stage IV Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
University of Nebraska
Testing effectiveness (Phase 2)Study completedNCT04569838
What this trial is testing

Evaluate the Efficacy and Safety of Bendamustine Hydrochloride Injection

Who this might be right for
Indolent B-Cell Non-Hodgkin's Lymphomas
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 91
Testing effectiveness (Phase 2)Study completedNCT00571493
What this trial is testing

VELCADE®-BEAM and Autologous Hematopoietic Stem Cell Transplantation for Non-Hodgkin's Lymphoma, or Mantle Cell Lymphoma

Who this might be right for
Non-hodgkin's LymphomaMantle Cell Lymphoma
University of Nebraska 42
Testing effectiveness (Phase 2)Ended earlyNCT03578198
What this trial is testing

Rituximab Plus MG4101 Indolent CD20-positive Non-Hodgkin Lymphoma (NHL)

Who this might be right for
CD20-positive Non-Hodgkin Lymphoma
Seoul National University Hospital 12
Testing effectiveness (Phase 2)Study completedNCT01514344
What this trial is testing

Intralesional Rituximab for the Treatment of Conjunctival Indolent Lymphoma

Who this might be right for
Ocular Adnexal Mucosa-Associated Lymphoid Tissue Lymphoma
Andres J. M. Ferreri 20
Testing effectiveness (Phase 2)Study completedNCT00179673
What this trial is testing

Lenalidomide (Revlimid®, CC-5013) in Subjects With Relapsed or Refractory Indolent Non-Hodgkin's Lymphoma

Who this might be right for
Non-Hodgkins Lymphoma
Celgene 43
Early research (Phase 1)Study completedNCT00058227
What this trial is testing

Alvocidib, Fludarabine Phosphate, and Rituximab in Treating Patients With Lymphoproliferative Disorders or Mantle Cell Lymphoma

Who this might be right for
B-cell Chronic Lymphocytic LeukemiaContiguous Stage II Grade 1 Follicular LymphomaContiguous Stage II Grade 2 Follicular Lymphoma+40 more
National Cancer Institute (NCI) 37
Testing effectiveness (Phase 2)Study completedNCT02207062
What this trial is testing

Ibrutinib in Treating Patients With Relapsed or Refractory Transformed Indolent B-cell Non-Hodgkin Lymphoma

Who this might be right for
Recurrent Transformed B-Cell Non-Hodgkin LymphomaRefractory Transformed B-Cell Non-Hodgkin Lymphoma
University of Washington 20
Next Page